, Volume 187, Issue 2, pp 128–135 | Cite as

The Association Between Depressive Symptoms and Acute Exacerbations of COPD

  • Jeffrey H. Jennings
  • Bruno DiGiovine
  • Dany Obeid
  • Cathy Frank



Depression is an important comorbidity for patients with chronic obstructive pulmonary disease (COPD). The association between depression and acute exacerbations of COPD is unknown. This study was designed to determine the frequency of COPD exacerbations in outpatients with and without depressive symptoms.


In this retrospective cohort study, patients with a primary diagnosis of COPD were followed for 1 year after discharge from a pulmonary rehabilitation program and the frequency of exacerbations was recorded. Upon completion of the program, all patients were administered the Short-Form 36 Health Survey (SF-36), which contains a mental health domain. Patients were classified as having depressive symptoms based on their domain score, which was separately validated in a second population of patients.


Of the 194 patients with COPD who completed the pulmonary rehabilitation program, 32 (16.5%) had depressive symptoms. There were no differences in terms of age, race, pack-years, forced expiratory volume in 1 second (FEV1), 6-minute walk distance, body mass index, use of supplemental oxygen, use of inhaled steroids, or the Charlson Comorbidity Index between patients with and without depressive symptoms. Patients with depressive symptoms had more exacerbations in the following year (1.91 vs. 1.36; p = 0.02), were 2.8 times more likely to have ever had an exacerbation (95% confidence interval (CI), 1.1–7.3; p = 0.03), and suffered a first exacerbation earlier (148 days compared with 266 days; p = 0.04) than nondepressed patients.


COPD patients with depressive symptoms have a significantly higher risk for exacerbations. Early screening for depression in patients with COPD may help identify those patients at higher risk for subsequent exacerbations.


Chronic obstructive pulmonary disease Exacerbation Depression 


  1. 1.
    Seemungal TA, Donaldson GC, Paul EA et al (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1418–1422PubMedGoogle Scholar
  2. 2.
    Ball P, Harris JM, Lowson D et al (1995) Acute infective exacerbations of chronic bronchitis. QJM 88:61–68PubMedGoogle Scholar
  3. 3.
    Donaldson GC, Seemungal TA, Patel IS et al (2003) Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 22:931–936. doi: 10.1183/09031936.03.00038303 PubMedCrossRefGoogle Scholar
  4. 4.
    Almagro P, Barreiro B, Ochoa de Echaguen A et al (2006) Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 73:311–317. doi: 10.1159/000088092 PubMedCrossRefGoogle Scholar
  5. 5.
    Kanner RE, Anthonisen NR, Connett JE (2001) Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164:358–364PubMedGoogle Scholar
  6. 6.
    van Manen JG, Bindels PJ, Dekker FW et al (2002) Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 57:412–416. doi: 10.1136/thorax.57.5.412 PubMedCrossRefGoogle Scholar
  7. 7.
    van Ede L, Yzermans CJ, Brouwer HJ (1999) Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 54:688–692PubMedCrossRefGoogle Scholar
  8. 8.
    Yohannes AM, Baldwin RC, Connolly MJ (2000) Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 15:1090–1096. doi: 10.1002/1099-1166(200012)15:12<1090::AID-GPS249>3.0.CO;2-L PubMedCrossRefGoogle Scholar
  9. 9.
    Norwood R (2006) Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 12:113–117. doi: 10.1097/01.mcp.0000208450.50231.c6 PubMedCrossRefGoogle Scholar
  10. 10.
    Lacasse Y, Rousseau L, Maltais F (2001) Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 21:80–86. doi: 10.1097/00008483-200103000-00004 PubMedCrossRefGoogle Scholar
  11. 11.
    Light RW, Merrill EJ, Despars JA et al (1985) Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 87:35–38. doi: 10.1378/chest.87.1.35 PubMedCrossRefGoogle Scholar
  12. 12.
    Yohannes AM, Baldwin RC, Connolly MJ (2005) Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 34:491–496. doi: 10.1093/ageing/afi163 PubMedCrossRefGoogle Scholar
  13. 13.
    Almagro P, Calbo E, Ochoa de Echaguen A et al (2002) Mortality after hospitalization for COPD. Chest 121:1441–1448. doi: 10.1378/chest.121.5.1441 PubMedCrossRefGoogle Scholar
  14. 14.
    Felker B, Katon W, Hedrick SC et al (2001) The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 23:56–61. doi: 10.1016/S0163-8343(01)00127-X PubMedCrossRefGoogle Scholar
  15. 15.
    Kim HF, Kunik ME, Molinari VA et al (2000) Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 41:465–471. doi: 10.1176/appi.psy.41.6.465 PubMedCrossRefGoogle Scholar
  16. 16.
    Ng TP, Niti M, Tan WC et al (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167:60–67. doi: 10.1001/archinte.167.1.60 PubMedCrossRefGoogle Scholar
  17. 17.
    American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77–S121Google Scholar
  18. 18.
    American Thoracic Society (1995) Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 152:1107–1136Google Scholar
  19. 19.
    Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383. doi: 10.1016/0021-9681(87)90171-8 PubMedCrossRefGoogle Scholar
  20. 20.
    Guerra CE, McDonald VJ, Ravenell KL et al (2008) Effect of race on patient expectations regarding their primary care physicians. Fam Pract 25:49–55PubMedCrossRefGoogle Scholar
  21. 21.
    Kiefe CI, Funkhouser E, Fouad MN et al (1998) Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 13:357–365. doi: 10.1046/j.1525-1497.1998.00115.x PubMedCrossRefGoogle Scholar
  22. 22.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483. doi: 10.1097/00005650-199206000-00002 PubMedCrossRefGoogle Scholar
  23. 23.
    Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedGoogle Scholar
  24. 24.
    Burge PS, Calverley PM, Jones PW et al (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320:1297–1303. doi: 10.1136/bmj.320.7245.1297 PubMedCrossRefGoogle Scholar
  25. 25.
    Perera WR, Hurst JR, Wilkinson TM et al (2007) Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 29:527–534. doi: 10.1183/09031936.00092506 PubMedCrossRefGoogle Scholar
  26. 26.
    Dahlen I, Janson C (2002) Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 122:1633–1637. doi: 10.1378/chest.122.5.1633 PubMedCrossRefGoogle Scholar
  27. 27.
    Cao Z, Ong KC, Eng P et al (2006) Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 11:188–195. doi: 10.1111/j.1440-1843.2006.00819.x PubMedCrossRefGoogle Scholar
  28. 28.
    Gudmundsson G, Gislason T, Janson C et al (2005) Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 26:414–419. doi: 10.1183/09031936.05.00078504 PubMedCrossRefGoogle Scholar
  29. 29.
    Quint JK, Baghai-Ravary R, Donaldson GC et al (2008) Relationship between depression and exacerbations in COPD. Eur Respir J 32:53–60. doi: 10.1183/09031936.00120107 PubMedCrossRefGoogle Scholar
  30. 30.
    Xu W, Collet JP, Shapiro S et al (2008) Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 178:913–920. doi: 10.1164/rccm.200804-619OC PubMedCrossRefGoogle Scholar
  31. 31.
    Burack JH, Barrett DC, Stall RD et al (1993) Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 270:2568–2573. doi: 10.1001/jama.270.21.2568 PubMedCrossRefGoogle Scholar
  32. 32.
    Leserman J (2003) HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry 54:295–306. doi: 10.1016/S0006-3223(03)00323-8 PubMedCrossRefGoogle Scholar
  33. 33.
    Leserman J, Jackson ED, Petitto JM et al (1999) Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med 61:397–406PubMedGoogle Scholar
  34. 34.
    Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5:617–625. doi: 10.1016/S1470-2045(04)01597-9 PubMedCrossRefGoogle Scholar
  35. 35.
    Zorrilla EP, Luborsky L, McKay JR et al (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199–226. doi: 10.1006/brbi.2000.0597 PubMedCrossRefGoogle Scholar
  36. 36.
    Lingam R, Scott J (2002) Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105:164–172. doi: 10.1034/j.1600-0447.2002.1r084.x PubMedCrossRefGoogle Scholar
  37. 37.
    Nemeroff CB (2003) Improving antidepressant adherence. J Clin Psychiatry 64(Suppl 18):25–30PubMedGoogle Scholar
  38. 38.
    Alsaeedi A, Sin DD, McAlister FA (2002) The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 113:59–65. doi: 10.1016/S0002-9343(02)01143-9 PubMedCrossRefGoogle Scholar
  39. 39.
    Calverley PM, Anderson JA, Celli B et al (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775–789. doi: 10.1056/NEJMoa063070 PubMedCrossRefGoogle Scholar
  40. 40.
    Miravitlles M, Espinosa C, Fernandez-Laso E et al (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 116:40–46. doi: 10.1378/chest.116.1.40 PubMedCrossRefGoogle Scholar
  41. 41.
    Glassman AH, Helzer JE, Covey LS et al (1990) Smoking, smoking cessation, and major depression. JAMA 264:1546–1549. doi: 10.1001/jama.264.12.1546 PubMedCrossRefGoogle Scholar
  42. 42.
    Kendler KS, Neale MC, MacLean CJ et al (1993) Smoking and major depression. A causal analysis. Arch Gen Psychiatry 50:36–43PubMedGoogle Scholar
  43. 43.
    Parchman ML (1991) Recognition of depression in patients who smoke. J Fam Pract 33:255–258PubMedGoogle Scholar
  44. 44.
    Brown C, Madden PA, Palenchar DR, Cooper-Patrick L (2000) The association between depressive symptoms and cigarette smoking in an urban primary care sample. Int J Psychiatry Med 30:15–26. doi: 10.2190/NY79-CJ0H-VBAY-5M1U PubMedCrossRefGoogle Scholar
  45. 45.
    Laurin C, Lavoie KL, Bacon SL et al (2007) Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 132:148–155. doi: 10.1378/chest.07-0134 PubMedCrossRefGoogle Scholar
  46. 46.
    Martinez FJ, Curtis JL, Sciurba F et al (2007) Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 176:243–252. doi: 10.1164/rccm.200606-828OC PubMedCrossRefGoogle Scholar
  47. 47.
    Chavannes NH, Huibers MJ, Schermer TR et al (2005) Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract 22:604–607. doi: 10.1093/fampra/cmi056 PubMedCrossRefGoogle Scholar
  48. 48.
    Kessler RC, McGonagle KA, Zhao S et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19PubMedGoogle Scholar
  49. 49.
    Furlanetto LM, Mendlowicz MV, Romildo Bueno J (2005) The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affect Disord 86:87–91. doi: 10.1016/j.jad.2004.12.011 PubMedCrossRefGoogle Scholar
  50. 50.
    Lustman PJ, Clouse RE, Griffith LS et al (1997) Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 59:24–31PubMedGoogle Scholar
  51. 51.
    Watnick S, Wang PL, Demadura T et al (2005) Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis 46:919–924. doi: 10.1053/j.ajkd.2005.08.006 PubMedCrossRefGoogle Scholar
  52. 52.
    van der Valk P, Monninkhof E, van der Palen J et al (2002) Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med 166:1358–1363. doi: 10.1164/rccm.200206-512OC PubMedCrossRefGoogle Scholar
  53. 53.
    Capuron L, Gumnick JF, Musselman DL et al (2002) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26:643–652. doi: 10.1016/S0893-133X(01)00407-9 PubMedCrossRefGoogle Scholar
  54. 54.
    Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR (2003) Cytokine-induced sickness behavior. Brain Behav Immun 17(Suppl 1):S112–S118. doi: 10.1016/S0889-1591(02)00077-6 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Jeffrey H. Jennings
    • 1
  • Bruno DiGiovine
    • 1
  • Dany Obeid
    • 1
  • Cathy Frank
    • 2
  1. 1.Division of Pulmonary and Critical Care MedicineHenry Ford Health SystemDetroitUSA
  2. 2.Behavioral Health ServicesHenry Ford Health SystemDetroitUSA

Personalised recommendations